Global Neuromodulation Market (2022 to 2028) - Size, Share & Industry Trends Analysis Report
June 17, 2022 05:53 ET
|
Research and Markets
Dublin, June 17, 2022 (GLOBE NEWSWIRE) -- The "Global Neuromodulation Market By Technology (Internal and External), By Biomaterial, By Application, By Regional Outlook and Forecast, 2022 - 2028"...
Global Neuromodulation Market to Reach $4.3 Bn Globally, by 2030, at 6.2% CAGR: Says AMR
June 15, 2022 07:47 ET
|
Allied Market Research
Portland, OR, June 15, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Neuromodulation Market was estimated at $2.48 billion in 2020, and is...
With 9.5 % CAGR, Neuromodulation Devices Market Size worth USD 9.34 billion by 2026
June 13, 2022 05:49 ET
|
Fortune Business Insights
Pune, India, June 13, 2022 (GLOBE NEWSWIRE) -- The global neuromodulation devices market size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period....
PathMaker Neurosystems Receives $100,000 START Award from MassVentures
June 08, 2022 07:00 ET
|
PathMaker Neurosystems Inc.
BOSTON, June 08, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
CVRx® Receives MR-Conditional Labeling Approval for its Barostim™ Heart Failure System
May 09, 2022 08:30 ET
|
CVRx, Inc.
Heart failure patients implanted with Barostim can now receive conditional MRI scans MINNEAPOLIS, May 09, 2022 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), developer of the world’s...
PathMaker Neurosystems Initiates U.S. Multi-Center Trial Evaluating MyoRegulator® for the Non-Invasive Treatment of Post-Stroke Spasticity
March 07, 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON and PARIS, March 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc., (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the...
Worldwide Nerve Repair & Regeneration Industry to 2026 - Availability of Therapies for Treatment of Various Issues Presents Opportunities
March 04, 2022 06:18 ET
|
Research and Markets
Dublin, March 04, 2022 (GLOBE NEWSWIRE) -- The "Global Nerve Repair & Regeneration Market (2021-2026) by Product, Application, Geography, Competitive Analysis and the Impact of Covid-19 with...
Groundbreaking Study Establishes Non-surgical Treatment Modality for Bowel Function in Individuals Living With Spinal Cord Injury
February 17, 2022 10:00 ET
|
SpineX
LOS ANGELES, Feb. 17, 2022 (GLOBE NEWSWIRE) -- SpineX, Inc., today announced the publication of new data in the esteemed neuroscience journal, Frontiers in Neuroscience. This new publication...
PathMaker Neurosystems Awarded CERF Medical Electronics Prize for Amyotrophic Lateral Sclerosis
February 07, 2022 06:00 ET
|
PathMaker Neurosystems Inc.
BOSTON, Feb. 07, 2022 (GLOBE NEWSWIRE) -- PathMaker Neurosystems Inc. (“PathMaker”), a near-commercial stage neuromodulation company developing breakthrough non-invasive systems for the treatment of...
Worldwide Deep Brain Stimulation Devices Industry to 2026 - Key Drivers and Challenges
January 24, 2022 04:48 ET
|
Research and Markets
Dublin, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The "Global Deep Brain Stimulation (DBS) Devices Market, By Product Type (Single-channel Deep Brain Stimulator, Dual-channel Deep Brain Stimulator), By Type...